|

Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India

RECRUITINGSponsored by International Agency for Research on Cancer
Actively Recruiting
SponsorInternational Agency for Research on Cancer
Started2020-10-01
Est. completion2026-10-30
Eligibility
Age18 Years – 22 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04588402

Summary

This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.

Eligibility

Age: 18 Years – 22 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women aged 18 to 22 years, resident of Sikkim and married.
* Pregnancy will not be considered as exclusion criteria.
* Sample collection should be avoided during active menstruation.

Exclusion Criteria:

* Women who do not provide written consent
* Women who are not able to cooperate in collection of cervical cell sample or respond to questions due to any acute or severe mental and physical illnesses.
* Women who had undergone hysterectomy.
* Vaccinated in research project

Conditions2

CancerCervical Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.